Dupilumab's Real‐World Efficacy and Safety Across Age Groups for Children and Adolescents With Paediatric Atopic Dermatitis

Key Points

• This research aims to evaluate the real-world effectiveness and safety of dupilumab in treating paediatric atopic dermatitis.
• Observed paediatric patients receiving dupilumab treatment
• Evaluated improvements in skin condition
• Assessed safety outcomes by age group
• Significant improvements in atopic dermatitis symptoms were noted
• Safety profile of dupilumab was acceptable across different ages
• Efficacy was consistent, regardless of patient age

Abstract